Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.

about

Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting

P2860

Q58795687-B0392C3C-E3F6-4D68-AAE6-01F688E43494

P2860

Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.

Item

http://www.wikidata.org/entity/Q40488554

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Commercial strain-derived clin ...... without higher pathogenicity.

@en

type

Item

label

Commercial strain-derived clin ...... without higher pathogenicity.

@en

prefLabel

Commercial strain-derived clin ...... without higher pathogenicity.

@en

P1476

Commercial strain-derived clin ...... s without higher pathogenicity

@en

P2093

Edit Urbán

http://www.w3.org/2001/XMLSchema#string

Enikő Boros

http://www.w3.org/2001/XMLSchema#string

Imre Zsuga

http://www.w3.org/2001/XMLSchema#string

István Pócsi

http://www.w3.org/2001/XMLSchema#string

László Majoros

http://www.w3.org/2001/XMLSchema#string

Matthias Sipiczki

http://www.w3.org/2001/XMLSchema#string

Zsuzsa Antunovics

http://www.w3.org/2001/XMLSchema#string

P2860

Population genomics of domestic and wild yeasts

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review

Review of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humans

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system

Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces.

Pathogenic potential of Saccharomyces strains isolated from dietary supplements

Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains.

DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans.

Invasive Saccharomyces infection: a comprehensive review.

Saccharomyces cerevisiae fungemia: an emerging infectious disease.

P31

scholarly article

P356

10.1002/MNFR.201601099

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28731263

http://www.w3.org/2001/XMLSchema#string

Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.

about

P2860

P2860

Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698